BSEInsider Trading / SASTResults22 Jun 2026
Dr Reddys Laboratories Ltd
Intimation regarding Closure of Trading window
Dr. Reddy's Laboratories Ltd. announced that its Board of Directors will convene on July 22, 2026, to approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. In accordance with SEBI insider trading regulations, the trading window for the company's securities will be closed from June 24, 2026, until July 24, 2026. This closure is standard practice ahead of financial result announcements to prevent insider trading.
BSEBoard Meeting22 Jun 2026
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/07/2026 ,inter alia, to consider and approve the Un-audited Standalone ....
Dr. Reddy's Laboratories Ltd. announced that its Board of Directors will convene on July 22, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. This is a routine regulatory filing ahead of the quarterly earnings release. Concurrently, the trading window for the company's securities will remain closed from June 24, 2026, until July 24, 2026, for designated persons.